Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Identify the ideal low-cost index funds for retirement using transparent criteria and performance benchmarks to guide your choices.
27,037 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Looking to find a better space stock: spacemobile? This guide breaks down AST SpaceMobile and Rocket Lab, weighing te...
Dive into 2023 credit card bonus offer reviews to separate hype from value. This guide breaks down what actually paid...
Robinhood has evolved from a simple trading app to a platform with broader fintech ambitions. This article explores p...
PepsiCo stock faces a potential move toward $180 as analysts cite World Cup-driven demand, cost cuts, and internation...
President Trump announces plans for the first new U.S. oil refinery in nearly five decades, backed by Reliance Indust...
Investors are weighing XRP's future over a three-year horizon. This article lays out a realistic outlook, three scena...
Loan brokerages are expanding headcount and GCI, but margins are thinning. A new industry look shows why growth often...
Remitly Global surged in early 2026 as it grabbed remittance market share and turned the corner on profitability. Thi...
A data storage chief explains why AI returns vary by use case and shares concrete examples of where investments pay o...
A leading XRPL validator announced opposition to additional reserve reductions, reviving a divide in the community ov...
A major broker cuts Alibaba's target to $170 after a sharp drop in Q3 profits, driven by heavy AI investment. The clo...